Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL314P is a *pseudogene* of the 7SL RNA (signal recognition particle RNA) family, located in the cytoplasm. Unlike canonical 7SL RNA, which is an essential component of the signal recognition particle responsible for directing proteins to the endoplasmic reticulum[5], pseudogenes such as RN7SL314P do not encode functional RNA molecules due to disabling mutations or truncations[2]. Pseudogenes are commonly inactive; while some pseudogenes may acquire regulatory roles through non-coding RNA transcripts, there is no direct evidence for functional relevance or disease association of RN7SL314P[1][2][4]. Often, pseudogenes are of note in genomic studies for annotation purposes or evolutionary analysis, but they are not considered therapeutic targets. If you are seeking information about the *functional 7SL RNA*, it has distinct biological roles in protein targeting, translation regulation, cellular stress responses, and even involvement in cancer via extracellular vesicle transfer[3][5]. However, **RN7SL314P** itself is a nonfunctional genomic copy with no direct drug targeting or disease relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 314, pseudogene (RN7SL314P).